Dr. Christopher M. Rombaoa, MD

Dr. Rombaoa practices at Golden Gate Endoscopy Center in San Francisco, California.

Dr. Rombaoa's NPI, 1225457211, was assigned on April 7, 2014. Dr. Rombaoa graduated from Tufts University School Of Medicine in 2014. Dr. Rombaoa's California license number on file is 1147334.

Dr. Rombaoa's primary practice is Golden Gate Endoscopy Center, at 3370 Geary Boulevard, First Floor, San Francisco, CA 94118. The practice phone is (415) 379-7500.

Dr. Rombaoa's primary practice is Golden Gate Endoscopy Center in San Francisco, California. Dr. Rombaoa is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Rombaoa to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rombaoa practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Rombaoa's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Rombaoa is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Rombaoa has a license on file in California.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, gastrointestinal bleeding, hemorrhoids and hepatitis c among the conditions Dr. Rombaoa treats.

CMS data shows 513 Medicare services from Dr. Rombaoa across 12 procedure codes in 2024, for 218 Medicare patients. Medicare paid $56,527 for them.

CMS counts 218 Medicare patients who saw Dr. Rombaoa in 2024. The largest group is 65 to 74, with 105 patients. 73% of them have high cholesterol, and 65% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rombaoa's median patient age at 56, with 49% women.

In 2024, Dr. Rombaoa wrote 599 Medicare Part D claims for 183 patients. 68% of them were for generic drugs. CMS names the drug for 462 of them, across 13 drugs with 11 or more claims each, at $127,411 in total drug cost. In 2023, CMS named 380 claims across 13 drugs.

Dr. Rombaoa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rombaoa as offering telehealth. CMS counts 59 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Rombaoa, more than 66% of the clinicians it reports for that procedure.

CMS Open Payments shows 92 general payments to Dr. Rombaoa from 20 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 56% of the total. Olympus Medical Systems Corporation paid the most, $3,206.

Dr. Rombaoa graduated from Tufts University School Of Medicine in 2014.

Dr. Rombaoa is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.